medigraphic.com
ISSN 0016-3813 (Print)

2008, Number 2

<< Back Next >>

Gac Med Mex 2008; 144 (2)

Evolución final de recién nacidos prematuros operados y no operados por persistencia del conducto arterioso

Tapia-Rombo CA, Calvo-Rangel KM, Saucedo-Zavala VJ, Mora-Folb JR, Santiago-Romo JE

Language: Spanish
References: 39
Page: 111-120
PDF size: 71.98 Kb.


ABSTRACT

Background: Patent ductus arteriosus (PDA) in the preterm neonate (PTN) with respiratory distress is frequent and there are controversies related to its medical and/or surgical treatment. The goal of the present study was to compare the outcome between the two groups of newborns with PDA, operated (group A) and not operated on (group B); and to determine the internal diameter (DI) in ductus arteriosus (DA) on outcome.
Material and methods: The clinical records of PTN hospitalized from January 1999 to January 2002, discharged either by improvement or death, were retrolectively analyzed. Statistical analysis was carried out using the descriptive and inferential statistic. The statistical significance was considered at p‹0.05.
Results: The was significant difference in DI in DA in favor group A with p‹0.01; and DI of 2 mm or more showed significant difference too in favor of group A with a p=0.0006. The mortality was similar in the two groups.
Conclusions: We concluded that in the PTN with significant PDA should intervene medical or surgically and without those data but with DI of 2 mm or more of DA, also.


REFERENCES

  1. Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandins inhibitors in PDA pathophysiology and treatment. Clin Perinatol 1995;22:457-477.

  2. Reller MD, Rice MJ, Mc Donald RW. Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993;122:S59-S62.

  3. Weiss H, Cooper B, Brook M, Schlueter M, Clyman RI. Factors determining reopening of the ductus arteriosus after succesful clinical closure with indomethacin. J Pediatr 1995;127:466-471.

  4. Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984;104:915-920.

  5. Evans N, Moorcraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child 1992;67:1169-1173.

  6. Evans N, Archer LN. Postnatal circulatory adaptation in healty term and preterm neonates. Arch Dis Child 1990;65:24-26.

  7. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994;125:270-277.

  8. Jacob J, Gluck L, DiSessa T, Edwards D, Kulovich M, Kurlinski J, et al. The contribution of PDA in the neonate with severe RDS. J Pediatr 1980;96:79-87.

  9. Evans N. Diagnosis of patent ductus arteriosus in preterm newborn. Arch Dis Child 1993; 68:58-61.

  10. Santamaría-Díaz H, Gómez-Gómez M. Persistencia del conducto arterioso. En: Santamaría-Díaz H, Gómez-Gómez M, editores. Cardiología neonatal. México: DEM; 2001. pp. 55-61.

  11. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-779.

  12. Kluckow M, Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. J Pediatr 1996;129: 506-512.

  13. Yeh TF, Raval D, Luken J, Thalji A, Lilien L, Pildes RS. Clinical evaluation of premature infants with patent ductus arteriosus: a scoring system with echocardiogram, acid-base, and blood gas correlations. Crit Care Med 1981;9:655-657.

  14. Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980;302:598-604.

  15. Brion LP, Campbell DE. Furosemide in indomethacin- treated infants-systematic review metaanalysis. Pediatr Nephrol 1999;13:212-218.

  16. Morales P, Rastogi A, Bez ML, Akintorin SM, Pyati S, Arides SM, Pildes RS. Effect of dexamethasone therapy on the neonatal ductus arteriosus. Pediatr Cardiol 1998;19:225-229.

  17. Rennie JM, Cooke RW. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991;66:55-58.

  18. Van Overmeire B,Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 1997; 76:F179 -F184.

  19. Bellinii C, Campomane F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ 2006; 174:1843-1844.

  20. Trus T, Winthrop AL, Pipe S, Shah J, Langer JC, Lau GY. Optimal management of the patent ductus arteriosus in the neonate weighing less than 800 gr. J Pediatr Surg 1993;28:1137-1139.

  21. Pérez CA, Bustorff-Silva JM, Villaseñor E, Fonkalsrud EW, Atkinson JB. Surgical ligation of patent ductus arteriosus in very low birth weight infants: is it safe? Am Surg 1998;64:1007-1009.

  22. Palder SB, Schwarts MZ, Tyson KR. Management of patent ductus arteriosus: a comparison of operative vs pharmacologic treatment. J Pediatr 1987;22:1171-1174.

  23. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978;93:647-651.

  24. Bancalari E, Claure N, González A. Biol. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005;88:192-201.

  25. Walsh MC, Kliegman RM. Enterocoloitis necrosante: tratamiento basado en criterios de establecimiento de etapas. Clin Pediatr Norteam 1986;1:187-209.

  26. Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage: Clinical course and outcomes among very low birth weight infants. Arch Pediatr Adolesc Med 1999;153:715-721.

  27. Baptista MJ, Correia-Pinto J, Areias JC, Guimaraes H. Patient ductus arteriosus in neonatal intensive care. Rev Port Cardiol 1999;18:1095-1100.

  28. San Luis R, López VJ, Villalpando C, Vázquez J, Santamaría H, Jodas J. Persistencia del conducto arterioso. Experiencia médico-quirúrgica. Bol Med Hosp Infant Mex 1992;49:884-885.

  29. Ledesma M, Gómez FD, Alva-Espinosa C, Argüero-Sánchez R. Cierre transcutáneo del conducto arterioso con Coils. Resultados inmediatos. Experiencia inicial en México. Arch Inst Cardiol Mex 1996;66:419-422.

  30. Munayer-Calderón J, Aldana-Pérez T, San Luis-Miranda R, Maza-Juárez G, Lázaro-Castillo JL, Ramírez-Reyes H, et al. Oclusión de la persistencia del conducto arterioso con un dispositivo Glanturco-Grifka. Primer caso en el Instituto Mexicano del Seguro Social (IMSS). Arch Inst Cardiol Mex 2000;70:403-406.

  31. Quibrera-Matienzo JA, Hernández-Mejía R, Beltrán-Nevarez O, De los Ríos-Ibarra MO. Cierre transcateterismo del conducto arterioso persistente: reporte de siete casos en el Hospital General de Culiacán “Bernardo J. Gastélum”. Bol Med Hosp Infant Mex 2001;58:312-319.

  32. Dooley KJ. Management of the premature infant with a patent ductus arteriosus. Clin Ped North Am 1984;31:1154-1174.

  33. Ekici F, Atasay B, Gunlemez A, Nacar N, Tutar E, Atalay S, Eyileten Z, Uysalel A, Arsan S. Mangement of patent ductus artriosus in preterm infants. Anadolu Kardiyol Derg 2006;6:28-33.

  34. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus neccessary ? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F235-F239.

  35. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419-F422.

  36. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 2002;103:75-77.

  37. Jaillard S, Larrue B, Rakza T, Magnenant E, Warenbourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg 2006;8:234-235.

  38. Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration in the fetal and neonatal ductus arteriosus. Am J Dis Child 1993;147:187-192.

  39. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE, Payne NR. Prophylactic indomethacin therapy in the first twenty four hours of life for the prevention of patent ductus arteriosus in the delivery room. J Pediatr 1996;128:631-637.




2020     |     www.medigraphic.com